Stop spending money on glassine paper! In this tutorial I'll show you exactly how to make your own at home using supplies you ...

Create a beautiful paper ice cream cone decoration with this simple and fun papercraft project for all skill levels. #PaperCraft #DIYDecor #CreativeIdeas ...

ROANOKE, Va. (WDBJ) - Bill is a Vietnam era veteran who served in the U.S. Army as an electronic instructor on the then secret HAWK surface-to-air missile system at the Ordinance Guided Missile School ...

Higher sales of cancer treatments helped fuel better-than-expected first-quarter sales and profit for drugmaker Pfizer PFE1.36%increase; up pointing triangle. Pfizer also reaffirmed its sales and ...

A major biotech company is leaving the Bay Area. Pfizer is abandoning its research site at 181 Oyster Point Blvd. in South San Francisco. The biotech company will move out of the building by the end ...

This week, Pfizer and French vaccine company, Valneva, released phase 3 clinical trial data for PF-0730740, a four-dose Lyme disease vaccine they developed together that is about 70% effective. While ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see pushback from the government following studies done on the vaccine. "What ...

Pfizer said it is working closely with its biotech partners to “ensure continuity and the successful transition of work.” (iStock/Getty Images Plus) As pharmas like Eli Lilly and Roche bolster their ...

That's the good news. The bad news is that while Pfizer "beat" on both sales and adjusted earnings, its earnings as calculated according to generally accepted accounting principles (GAAP) showed a ...

Pfizer Inc. enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution, despite an aggressive strategic repositioning. The $10 billion Metsera acquisition ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. Limited time: Save 25% on NBC ...

Pfizer Inc. is doubling down on the booming weight-loss drug race, with CEO Albert Bourla declaring the company will be a "formidable competitor" after securing a $10 billion deal to acquire ...